You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.



A chat with Val Romberg

Kedrion Biopharma's new CEO shares his views

read more 


Turkey, Kedrion supports the XVII International Congress on Hemophilia

The present and future role of Factor VIII at the center of the symposium supported by Kedrion

read more 


Kedrion is one of the main sponsors of the National SISET Conference

The company sponsors two scientific lectures, a testament to its close ties with the world of medicine and science

read more 
  1. EVENTS - 25-06-2020

    Kedrion supports the World Federation Of Hemophilia Virtual Summit 2020

    The company reaffirms its commitment to the patient community during the COVID-19 epidemic

    read more 
  2. CORPORATE - 22-06-2020

    Kedrion-Kamada collaboration, first batch of Covid-19 IG released in Israel

    The two companies are now working to expand the Clinical Development Program to the US

    read more 
  3. EVENTS - 28-04-2020

    Kedrion Biopharma supports the 2020 Primary Immunodeficiency Week

    The company stands alongside the global PI community

    read more 


For more information please contact: